Menu
Washingtoner
  • Home
  • Artificial Intelligence
  • Health
  • Technology
  • Entertainment
  • Software
  • Real Estate
  • Business
  • Education
Washingtoner

Matt Stuckert Joins Lineus Medical Board of Directors
Washingtoner/10286025

Trending...
  • OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
  • Arizona Pest Control Surpasses $200,000 in Contributions to Southern Arizona High School Sports and Education Programs
  • Spokane: City And County Seek Federal Grant to Plan for Road Network Wildfire Resilience
Matt Stuckert SafeBreak Vascular Lineus Medical
FAYETTEVILLE, Ark. - Washingtoner -- Lineus Medical is pleased to announce the appointment of Matt Stuckert to its Board of Directors. Stuckert was previously a member of the Lineus Technical Advisory Board.  Stuckert brings over a decade of sales leadership experience in the vascular access space, and has held key roles at Magnolia Medical, Becton Dickinson, CareFusion, Cardinal Health, Enturia, and Venetec.. Throughout his career, he has successfully built and led sales teams, and has driven commercial growth, particularly in the adoption of novel new vascular technologies.

His expertise in sales strategy and business development will be instrumental in guiding Lineus Medical's continued success. With a deep understanding of the vascular access market, Stuckert's knowledge will help support the growth of the company's flagship product, SafeBreak Vascular. Stuckert commented, "I am excited to join Lineus Medical's Board of Directors and contribute to the company's growth. SafeBreak Vascular is a game-changing vascular access device that directly addresses IV complications and improves patient experience, both critical issues in hospitals. I look forward to leveraging my experience to help expand SafeBreak's adoption and support the company's mission of improving IV care."

More on Washingtoner
  • The World's No.1 Superstar® Brings Christmas Back in Grand Style with Music, Cinematic Glamour, and Luxury Fashion
  • New Six-Figure Media Agreement Builds Powerful Momentum, Expanding Government Contracts, FBI Access and Growing AI Recognition: Cyabra (NAS DAQ: CYAB)
  • Christmas Beats Summer in Paris: Travel Photoshoots Peak on Dec. 30
  • Qscription Technologies Welcomes Joanna Krause, MD, MRMD to Its Clinical Advisory Board
  • Jamie Foxx's SKVLK Fest Sets the Record Straight on Stabbing Reports Following Star-Studded Celebration

Vance Clement, CEO of Lineus Medical said, "Matt Stuckert's extensive experience in vascular access sales and marketing makes him a valuable addition to our Board. His insights will be instrumental as we expand SafeBreak Vascular's presence in hospitals nationwide. We are excited to have him join our board as we continue to revolutionize what vascular access care looks like."

SafeBreak Vascular is the only break-away device for IV lines clinically proven to reduce IV complications¹. When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close, preventing medicine spills from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patient's infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money.1

About Lineus Medical

Lineus Medical is the developer of break-away technology proven to reduce IV restarts and complications¹. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn.

References:
1. Data on File

Contact
Vance Clement
***@lineusmed.com


Source: Lineus Medical
Filed Under: Health, Technology

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • HIRO Ostomy Belt Launch by Richard O'Hamill
  • New Omega-3 Fish Oil Under NIH Investigation: What Makes It Different From EPA and DHA?
  • Flags Lowered for Spokane County Sheriff Deputies
  • Technical Brief Examines Enterprise Integration Challenges as AI Agent Platforms Expand
  • ARADIA (Est. 1991) Launches First B2A Partner Program for AI
  • OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
  • Spokane: Drugs and Guns Seized in a Counter Narcotics Investigation
  • Brian G. Miller Co., LLC Receives Tier 1 Ranking in the 2027 Edition of Best Law Firms®
  • The Villari Firm, PLLC Named to the 2027 Edition of Best Law Firms
  • Spokane: City and County Issue Joint Housing and Homelessness Funding RFP
  • Spokane: Council Approves Additional Funding to Prepare for Inclement Weather
  • Bacchus Wine & Spirits and Michelin Guide–Recommended Ethel's Fancy to Host Exclusive LOUIS XIII Limited Edition Diwali Decanter Celebration
  • Arizona Pest Control Surpasses $200,000 in Contributions to Southern Arizona High School Sports and Education Programs
  • ZenaTech (NAS DAQ: ZENA) $1 Million in New Utility Contracts- Potential $2.5 Million Follow-On Opportunity Puts Its Drone Business in the Spotlight!
  • New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
  • Genuine Hospitality, LLC Selected to Operate Holiday Inn Express & Suites Jacksonville – Town Center
  • Shiokly Launches Online Marketplace to Help Singapore Home-Based Businesses Sell More, With First Product Listed Free
  • Freight Broker 911 and Milton Collier Introduce "What's The 911?"—A New Podcast Built on Real Talk, Real Freight, and Real Opportunity
  • PropAccount.com Launches PropWallet, Turning Prop Firm Payouts Into Repeat Sales
  • Spokane: City And County Seek Federal Grant to Plan for Road Network Wildfire Resilience
_catLbl0 _catLbl1

Popular on Washingtoner

  • Pre-Seed VC Martin Tobias Makes Fundraising Tool Available to Every Startup CEO as Investor Match - 248
  • New Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX) - 212
  • Final Week to Register for Free Spokane Community Conference - 189
  • Citizens for West Virginia Election Integrity Urges "FOR" on Amendment 1 - 178
  • Author Robert A. Robinson Introduces Anarchy at the AYP: - 138
  • LocalsVoted Launches: Local Rankings From Phone-Verified Votes, Not Paid Placement - 130
  • Kent Youth and Family Services Announces Sale of Watson Manor - 117
  • Simpalm Staffing Launches Tax Preparer Staffing for U.S. CPA Firms - 112
  • Meta Partnership Expanding as Omni One Orders Surge 3X -New Consumer Bundles, Defense Opportunities & AI Robotics: Virtuix Holdings: N A S D A Q: VTIX - 111
  • Self-Published Dad's Santa Book Finally Found After 3 Years on Amazon

Similar on Washingtoner

  • Commercial Sales Launch Following FDA Approval; National Sales Force Now in Action as January Shipments and Major Market Opportunity Take Shape
  • ViewDNS.info Launches Monitors, Alerting Teams the Moment Something Changes on Their Domains
  • Contracting Resources Group Named a 2027 Elev8 GovCon Honoree by OrangeSlices
  • New Six-Figure Media Agreement Builds Powerful Momentum, Expanding Government Contracts, FBI Access and Growing AI Recognition: Cyabra (NAS DAQ: CYAB)
  • Qscription Technologies Welcomes Joanna Krause, MD, MRMD to Its Clinical Advisory Board
  • Romanian Software Company ASSIST Software Ranks Second Nationally Among Large Enterprises in Its Category
  • New Omega-3 Fish Oil Under NIH Investigation: What Makes It Different From EPA and DHA?
  • Technical Brief Examines Enterprise Integration Challenges as AI Agent Platforms Expand
  • OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
  • ZenaTech (NAS DAQ: ZENA) $1 Million in New Utility Contracts- Potential $2.5 Million Follow-On Opportunity Puts Its Drone Business in the Spotlight!
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute